Clinical efficacy and safety of transcatheter aortic valve replacement for patients with severe pure native aortic regurgitation

Jun Chen, Yi Zhang, Jianfeng Liang, Shengfu Huang, Hengjun Xiao, Mingming Liang, Zexuan WuJournal of Zhejiang University (Medical Sciences) 2025 · DOI

This study, published in the Journal of Zhejiang University (Medical Sciences), evaluates the use of Transcatheter Aortic Valve Replacement (TAVR) for a particularly challenging condition: severe pure native aortic regurgitation (PNAR). By comparing two different surgical access routes—through the femoral artery (TF) and through the heart's apex (TA)—the researchers demonstrate that TAVR is a viable, life-saving alternative for high-risk patients who cannot undergo traditional open-heart surgery.

TL;DR

TAVR is traditionally used for "clogged" (stenotic) heart valves, but this study shows it is also effective for "leaky" (regurgitant) valves that lack the calcification usually needed to anchor a prosthetic. While both transfemoral and transapical approaches showed similar survival rates, the transfemoral route carried a significantly higher risk of heart rhythm disturbances requiring pacemakers.

What Problem Does This Paper Address?

The standard treatment for a leaky aortic valve (Aortic Regurgitation) is Surgical Aortic Valve Replacement (SAVR), an open-heart procedure. However, many elderly or frail patients are too high-risk for such invasive surgery.

TAVR was designed as a minimally invasive alternative, but it has a "grip" problem when it comes to PNAR. In Aortic Stenosis, the valve is covered in hard calcium deposits that provide a sturdy anchor for the TAVR device. In PNAR, the valve is often smooth and dilated, making it difficult to secure the prosthetic valve without it migrating, leaking, or falling into the ventricle. This paper investigates whether modern TAVR techniques and devices can safely overcome these anatomical hurdles.

Methods

The researchers conducted a retrospective analysis of 48 patients treated at the First Affiliated Hospital of Sun Yat-sen University between 2019 and 2025. They compared two primary surgical approaches:

  • TF-TAVR (n=25): Access via the femoral artery in the groin, typically using the VitaFlow valve system.
  • TA-TAVR (n=23): Access via a small incision in the chest directly into the apex of the heart, using the J-Valve system, which features a unique "clipping" mechanism designed for non-calcified valves.

The team used 3D CT modeling (MDCT) for precise pre-operative planning, measuring the aortic annulus, the left ventricular outflow tract (LVOT), and coronary artery heights to customize the approach for each patient.

Datasets

The study utilized a clinical dataset of 48 patients from a single high-volume center (Sun Yat-sen University). Patients were included if they had severe PNAR and were deemed "high-risk" or "inoperable" for traditional surgery based on European and American heart association guidelines.

Key Insights and Ideas

  • Anatomical Tailoring: The choice of entry route wasn't random. Patients in the TF-TAVR group generally had smaller aortic structures (annulus and LVOT diameters) and smaller "sinus" dimensions. TA-TAVR was preferred for patients with larger, more complex aortic root geometries.
  • The "Slippage" Solution: PNAR valves are notoriously difficult to anchor. The study achieved a high technical success rate (91.67%) by utilizing devices like the J-Valve, which uses mechanical feelers to "clip" onto the native valve leaflets, providing stability even without calcium.
  • The Conduction Trade-off: A major "aha" moment was the disparity in heart block events. The TF-TAVR group saw a 12% rate of high-grade atrioventricular blocks requiring permanent pacemakers, while the TA-TAVR group had zero such events. This suggests that the transapical route (and the J-Valve) may be gentler on the heart's electrical system in PNAR cases.

Key Results

  • Success Rates: Overall technical success was 91.67%, with a device success rate of 83.33%.
  • Heart Remodeling: Both groups saw significant improvements in heart size. The Left Ventricular End-Diastolic Diameter (LVEDD)—a measure of how much the heart has stretched due to the leak—decreased significantly in both groups (e.g., from ~65mm to ~53mm in the TA group).
  • Survival: In-hospital mortality was low at 4.17% (2 patients). At the one-year mark, there was no statistically significant difference in survival between the two surgical approaches.
  • Safety: TF-TAVR patients were more likely to experience new-onset conduction disturbances (12% vs 0% for TA-TAVR).

Limitations and Future Work

The authors acknowledge several limitations:

  • Sample Size: With only 48 patients, the study may lack the statistical power to detect rarer complications.
  • Single-Center Bias: The results reflect the expertise of a specific surgical team and may not be universally reproducible.
  • Short Follow-up: While one-year data is promising, the long-term durability of these valves in a "leaky" environment (where mechanical stresses differ from "clogged" environments) remains unknown.

Future research should focus on larger, multi-center randomized trials and the development of next-generation TAVR devices specifically engineered for the non-calcified PNAR anatomy.

Summary updated

Abstract

TAVR demonstrates high feasibility and acceptable safety for severe PNAR patients who are not suitable for conventional SAVR. Both TF-TAVR and TA-TAVR show comparable early postoperative efficacy and safety profiles.
BibTeX
@article{chen2025clinical,
  author = {Jun Chen and Yi Zhang and Jianfeng Liang and Shengfu Huang and Hengjun Xiao and Mingming Liang and Zexuan Wu},
  title = {{Clinical efficacy and safety of transcatheter aortic valve replacement for patients with severe pure native aortic regurgitation}},
  journal = {Journal of Zhejiang University (Medical Sciences)},
  year = {2025},
  doi = {10.3724/zdxbyxb-2024-0515},
}
Figure